Insulet | PODD - Дебиторская задолженность





Дебиторская задолженность Изменить Дата
Abbott USD 10.57B 171M 2025-12
Align Technology USD 1.13B 23.36M 2026-03
AtriCure USD 71.31M 4.66M 2026-03
Avanos Medical USD 103M 800K 2026-03
Baxter International USD 1.7B 310M 2026-03
Becton, Dickinson and Co. USD 2.2B 303M 2026-03
Boston Scientific USD 2.93B 98M 2025-12
Cardinal Health USD 13.65B 14M 2026-03
Cooper Companies USD 807.1M 21.9M 2025-12
Dexcom USD 1.09B 182.1M 2026-03
Edwards Lifesciences USD 912.1M 19.3M 2025-12
Eli Lilly USD 21.18B 1.02B 2026-03
Globus Medical USD 735.44M 8.23M 2026-03
ICU Medical USD 180.52M 11.03M 2025-12
Inogen USD 37.09M 4.11M 2024-06
Insulet USD 544.7M 27.8M 2026-03
Integra LifeSciences USD 264.41M 14.44M 2026-03
J&J USD 21.33B 3.72B 2025-12
Masimo USD 288.9M 103M 2026-03
Medtronic USD 6.36B 30M 2025-12
Merit Medical Systems USD 227M 3.39M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
Solventum Corp USD 1.35B 163M 2026-03
Stryker USD 3.57B 468M 2026-03
Tandem Diabetes Care USD 165.49M 39.55M 2025-12
Teleflex USD 365.53M 19.94M 2026-03
West Pharmaceutical Services USD 685.6M 111.2M 2026-03
Zimmer Biomet Holdings USD 1.73B 24.2M 2026-03